Molecular high-grade B cell lymphoma: defining a poor risk group requiring different approaches to therapy

Sha, C, Barrans, S, Cucco, F et al. (20 more authors) (2019) Molecular high-grade B cell lymphoma: defining a poor risk group requiring different approaches to therapy. Journal of Clinical Oncology, 37 (3). pp. 202-213. ISSN 0732-183X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 by American Society of Clinical Oncology. Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
Dates:
  • Published: January 2019
  • Accepted: 30 October 2018
  • Published (online): 3 December 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Molecular and Cellular Biology (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Funding Information:
FunderGrant number
MRCMR/L01629X/1
Bloodwise13052
Cancer Research UKC7845/A17723
Bloodwise15002
Depositing User: Symplectic Publications
Date Deposited: 06 Nov 2018 17:45
Last Modified: 28 Jan 2019 13:15
Status: Published
Publisher: American Society of Clinical Oncology
Identification Number: https://doi.org/10.1200/JCO.18.01314

Download

Share / Export

Statistics